Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004766537 | SCV005381244 | pathogenic | Metachromatic leukodystrophy | 2024-08-07 | criteria provided, single submitter | clinical testing | Variant summary: The variant involves the deletion of exons 1-8 in the ARSA gene. A presumed nomenclature of c.(?_-374)_(*2392_?)del has been designated for the purposes of this classification. This deletion includes the entire coding sequence of the gene. As the exact proximal and distal breakpoints are unknown, it may extend beyond the annotated region of the gene to include other flanking genes. This whole gene deletion was absent in 21694 control chromosomes (gnomAD Structural Variants database). Deletion of ARSA gene has been reported in the literature in at least an individual affected with Metachromatic Leukodystrophy (example: Coulter-Mackie_1995). This individual had a de novo constitutional ring chromosome 22 of maternal origin deleted for the ARSA gene. The following publication has been ascertained in the context of this evaluation (PMID: 8558556). ClinVar contains an entry for this variant (Variation ID: 526831). Based on the evidence outlined above, the variant was classified as pathogenic. |